Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 110.73B | 112.79B | 112.04B | 105.16B | 98.82B | 92.94B |
Gross Profit | 15.36B | 15.07B | 17.14B | 15.23B | 15.08B | 14.02B |
EBITDA | 5.73B | 6.92B | 10.50B | 8.41B | 9.00B | 8.37B |
Net Income | -3.15B | -4.19B | 1.75B | 399.00M | 621.00M | 300.00M |
Balance Sheet | ||||||
Total Assets | 117.94B | 122.34B | 119.46B | 113.77B | 114.38B | 113.73B |
Cash, Cash Equivalents and Short-Term Investments | 19.01B | 19.95B | 21.11B | 16.95B | 20.25B | 21.31B |
Total Debt | 26.18B | 26.11B | 22.68B | 22.81B | 25.46B | 28.34B |
Total Liabilities | 49.05B | 53.05B | 46.87B | 46.69B | 48.08B | 49.39B |
Stockholders Equity | 68.20B | 68.67B | 72.01B | 66.58B | 65.79B | 63.73B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.82B | 4.62B | 200.00M | 2.49B | 559.00M |
Operating Cash Flow | 0.00 | 6.25B | 10.74B | 5.87B | 7.10B | 5.64B |
Investing Cash Flow | 0.00 | -10.20B | -6.22B | -5.84B | -4.72B | -5.13B |
Financing Cash Flow | 0.00 | 2.07B | -1.01B | -4.03B | -3.73B | 8.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥24.36B | 7.10 | 6.46% | 0.36% | 248.87% | ||
74 Outperform | ¥15.77B | 7.20 | 3.64% | -5.40% | ― | ||
73 Outperform | ¥9.60B | 4.83 | 5.59% | 1.49% | 78.77% | ||
62 Neutral | C$5.25B | 11.07 | 18.94% | 3.79% | 5.08% | 6.52% | |
56 Neutral | ¥8.45B | ― | 2.68% | -3.96% | -462.50% | ||
52 Neutral | ¥16.39B | ― | 3.54% | 0.66% | -340.28% | ||
49 Neutral | ¥21.71B | ― | 3.54% | -1.68% | -240.66% |